Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Ready to take the next step
OL Research products are supplied in compliance with UK regulations governing research compounds.
This section of the program ensures exactly that
Dual agonists that activate both GLP-1 and GIP receptors tend to cause these side effects slightly more frequently than pure GLP-1 agonists
Retatrutide In the first phase 3 trial (TRIUMPH-4), participants lost an average of 28.7% of their body weight at 68 weeks on the highest dose (12mg), with the 9mg dose showing 26.4% weight loss
Understanding the place for GLP-1RA therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection
US$ 22.82
US$ 20.58
US$ 25.47
US$ 25.88
